triclabendazole sulfoxide has been researched along with albendazole in 3 studies
*Albendazole: A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38) [MeSH]
*Albendazole: A benzimidazole broad-spectrum anthelmintic structurally related to MEBENDAZOLE that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38) [MeSH]
| Studies (triclabendazole sulfoxide) | Trials (triclabendazole sulfoxide) | Recent Studies (post-2010) (triclabendazole sulfoxide) | Studies (albendazole) | Trials (albendazole) | Recent Studies (post-2010) (albendazole) |
|---|---|---|---|---|---|
| 30 | 1 | 16 | 4,981 | 539 | 2,033 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fairweather, I; Hoey, EM; Lawson, J; Robinson, MW; Trudgett, A | 1 |
| Alvarez, L; Fairweather, I; Lanusse, C; Mottier, L | 1 |
| Giri, P; Giri, S; Gupta, L; Joshi, V; Naidu, S; Patel, N; Srinivas, NR | 1 |
3 other study(ies) available for triclabendazole sulfoxide and albendazole
| Article | Year |
|---|---|
The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Biotransformation; Chromatography, High Pressure Liquid; Drug Resistance; Fasciola hepatica; Sheep; Sulfones; Sulfoxides; Triclabendazole | 2004 |
Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Benzimidazoles; Drug Resistance; Fasciola hepatica; Ivermectin; Sheep; Sulfoxides; Triclabendazole | 2006 |
In Vitro Drug-Drug Interaction Potential of Sulfoxide and/or Sulfone Metabolites of Albendazole, Triclabendazole , Aldicarb, Methiocarb, Montelukast and Ziprasidone.
Topics: Acetates; Albendazole; Aldicarb; Biotransformation; Cyclopropanes; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Methiocarb; Microsomes, Liver; Piperazines; Quinolines; Risk Assessment; Sulfides; Sulfones; Sulfoxides; Thiazoles; Triclabendazole | 2018 |